Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02988375 · ClinicalTrials.gov registry record · NA
Sleep to Prevent Evolving Affecting Disorders
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 1,385
- Enrollment target
NCT02988375 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 1,385 participants.
The verdict
NCT02988375, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,385 participants
- Enrollment target
Study Summary
The primary objective of the proposed research is to determine the efficacy of Digital Cognitive Behavior Therapy (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among insomniacs. In addition, we will identify salient sociological/environmental variables, such as age, sex, education, socioeconomic status (SES), racial/ethnic minority-status, work schedule, child-care responsibilities (i.e., having children under the age of 3), stigma, that moderate the effects of this intervention.
Interventions
- BEHAVIORAL Sleep Education
- BEHAVIORAL dCBTI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,385 participants |
| Start Date | 2016-03-08 |
| Est. Completion | 2018-09-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02988375
The ClinicalTrials.gov registry entry for NCT02988375 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,385 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sleep Education is the first listed.
NCT02988375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02988375 about?
NCT02988375 is a clinical study titled "Sleep to Prevent Evolving Affecting Disorders". The primary objective of the proposed research is to determine the efficacy of Digital Cognitive Behavior Therapy (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among insomniacs. In addition, we will identify salient sociological/environment...
What is the current status of trial NCT02988375?
This trial is currently completed. It is a NA study. The enrollment target is 1,385 participants. The study started on 2016-03-08. Estimated completion is 2018-09-13.
What interventions are being tested in trial NCT02988375?
The interventions under investigation include: Sleep Education (BEHAVIORAL), dCBTI (BEHAVIORAL).
Who is sponsoring clinical trial NCT02988375?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.